Elevated TAB182 enhances the radioresistance of esophageal squamous cell carcinoma through G2‐M checkpoint modulation

BACKGROUND: Radiotherapy is one of the main strategies for the treatment of esophageal squamous cell carcinoma (ESCC). However, treatment failure often occurs due to the emergence of radioresistance. In this study, we report a key regulator of radiation sensitivity, termed TAB182 that may become an...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Yuandong, Gao, Aidi, Li, Xiaoqing, Min, Han, He, Chao, Sun, Xinchen, Ding, Wei‐Qun, Zhou, Jundong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Cancer Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085956/
https://www.ncbi.nlm.nih.gov/pubmed/33787085
http://dx.doi.org/10.1002/cam4.3879

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085956/
https://www.ncbi.nlm.nih.gov/pubmed/33787085
http://dx.doi.org/10.1002/cam4.3879

Ejemplares similares